all AI news
DeepCRE: Revolutionizing Drug R&D with Cutting-Edge Computational Models
March 7, 2024, 5:42 a.m. | Yushuai Wu
cs.LG updates on arXiv.org arxiv.org
Abstract: The field of pharmaceutical development and therapeutic application both face substantial challenges. Therapeutic domain calls for more treatment alternatives while numerous promising pre-clinical drugs fail in clinical trails. One of the reasons is the inadequacy of Cross-drug Response Evaluation (CRE) during the late stage of drug development. Although in-silico CRE models offer a solution to this problem, existing methodologies are either limited to early development stages or lack the capacity for a comprehensive CRE analysis. …
abstract application arxiv challenges clinical computational cs.ai cs.lg development domain drug development drugs edge evaluation face pharmaceutical q-bio.qm r&d stage treatment type
More from arxiv.org / cs.LG updates on arXiv.org
Jobs in AI, ML, Big Data
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US
Research Engineer
@ Allora Labs | Remote
Ecosystem Manager
@ Allora Labs | Remote
Founding AI Engineer, Agents
@ Occam AI | New York
AI Engineer Intern, Agents
@ Occam AI | US